Silybin B

Silybin B
Product Name Silybin B
CAS No.: 142797-34-0
Catalog No.: CFN92916
Molecular Formula: C25H22O10
Molecular Weight: 482.44 g/mol
Purity: >=98%
Type of Compound: Flavonoids
Physical Desc.: Powder
Targets: Calcium Channel | ROS
Source: The herbs of Silybum marianum
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Price: $368/20mg
Silybin B and silybin A are potent inhibitors of both raloxifene 4'- and 6-glucuronidation in all enzyme systems; they show strong effects on cell growth inhibition and apoptosis induction in human chronic myeloid leukemia K562 cells. Silybin B exhibits 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging activity.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Agriculture.2022, 12(3), 342.
  • Sci Rep.2016, 6:25094
  • J Ethnopharmacol.2019, 228:132-141
  • J Drug Target.2016, 24:1-28
  • J Microbiol Biotechnol.2022, 32(2):141-148.
  • Oncotarget.2016, 8(51):88386-88400
  • Research Square2021, March 3rd.
  • GxABT2022, 2268.2:15515.
  • Pharm Biol.2016, 54(7):1255-62
  • Front Pharmacol.2021, 12:761922.
  • Silydianin

    Catalog No: CFN90242
    CAS No: 29782-68-1
    Price: $168/20mg
    Silyamandin

    Catalog No: CFN91143
    CAS No: 1009565-36-9
    Price: $413/5mg
    Silychristin B

    Catalog No: CFN95160
    CAS No: 879325-58-3
    Price: $318/5mg
    Isosilychristin

    Catalog No: CFN95369
    CAS No: 77182-66-2
    Price: $318/5mg
    2,3-Dehydrosilychristin

    Catalog No: CFN95370
    CAS No: 57499-41-9
    Price: $318/5mg
    Isosilybin

    Catalog No: CFN90260
    CAS No: 72581-71-6
    Price: $138/20mg
    Isosilybin A

    Catalog No: CFN91070
    CAS No: 142796-21-2
    Price: $218/5mg
    Isosilybin B

    Catalog No: CFN91071
    CAS No: 142796-22-3
    Price: $238/5mg
    Silymarin

    Catalog No: CFN99542
    CAS No: 22888-70-6
    Price: $30/20mg
    Silybin A

    Catalog No: CFN95149
    CAS No: 22888-70-6
    Price: $318/20mg
    Nat Prod Commun. 2011 Nov;6(11):1653-6.
    A comparison of the diastereoisomers, silybin A and silybin B, on the induction of apoptosis in K562 cells.[Pubmed: 22224281]
    Two diastereoisomers of silybin, silybin A and Silybin B, were separated from silymarin by HPLC in our previous study.
    METHODS AND RESULTS:
    The present study assessed the effects of the diastereoisomers on cell apoptosis, and compared these with their mixture, silybin, in human chronic myeloid leukemia K562 cells. Both isomers showed stronger effects on cell growth inhibition and apoptosis induction than silybin. Compared with Silybin B, silybin A showed higher effects on the production of intracellular reactive oxygen species and Ca2+.
    CONCLUSIONS:
    These results suggest that silybin A and Silybin B have similar potency on apoptosis induction with different oxidative effects. Antagonistic effects may exist between silybin A and Silybin B, partially through ROS production and Ca2+ increase.
    Drug Metab Dispos. 2015 Sep;43(9):1353-9.
    Milk Thistle Constituents Inhibit Raloxifene Intestinal Glucuronidation: A Potential Clinically Relevant Natural Product-Drug Interaction.[Pubmed: 26070840 ]
    Women at high risk of developing breast cancer are prescribed selective estrogen response modulators, including raloxifene, as chemoprevention. Patients often seek complementary and alternative treatment modalities, including herbal products, to supplement prescribed medications. Milk thistle preparations, including silibinin and silymarin, are top-selling herbal products that may be consumed by women taking raloxifene, which undergoes extensive first-pass glucuronidation in the intestine. Key constituents in milk thistle, flavonolignans, were previously shown to be potent inhibitors of intestinal UDP-glucuronosyl transferases (UGTs), with IC50s ≤ 10 μM. Taken together, milk thistle preparations may perpetrate unwanted interactions with raloxifene.
    METHODS AND RESULTS:
    The objective of this work was to evaluate the inhibitory effects of individual milk thistle constituents on the intestinal glucuronidation of raloxifene using human intestinal microsomes and human embryonic kidney cell lysates overexpressing UGT1A1, UGT1A8, and UGT1A10, isoforms highly expressed in the intestine that are critical to raloxifene clearance. The flavonolignans silybin A and Silybin B were potent inhibitors of both raloxifene 4'- and 6-glucuronidation in all enzyme systems. The Kis (human intestinal microsomes, 27-66 µM; UGT1A1, 3.2-8.3 µM; UGT1A8, 19-73 µM; and UGT1A10, 65-120 µM) encompassed reported intestinal tissue concentrations (20-310 µM), prompting prediction of clinical interaction risk using a mechanistic static model. Silibinin and silymarin were predicted to increase raloxifene systemic exposure by 4- to 5-fold, indicating high interaction risk that merits further evaluation.
    CONCLUSIONS:
    This systematic investigation of the potential interaction between a widely used herbal product and chemopreventive agent underscores the importance of understanding natural product-drug interactions in the context of cancer prevention.
    Journal of Molecular Catalysis B Enzymatic, 2014, 109:24-30.
    Enzymatic oxidative dimerization of silymarin flavonolignans.[Reference: WebLink]
    Dimerization of phenolic compounds can potentially enhance their biological (antioxidant) activity.
    METHODS AND RESULTS:
    We present here the selective oxidative dimerization of several flavonolignans from Silybum marianum seed extract, namely, silybin A (1a), Silybin B (1b), silychristin (3), and silydianin (4) catalyzed by a laccase from Trametes versicolor. Selective benzylation of C-7 OH group of both silybins ensured the priority of the dimerization reaction, avoiding thus polymerization. C-C homodimers connected via E-rings of silybin A and B and silydianin dimers were successfully isolated after respective debenzylation. On the contrary, dimerization of 7-O-benzyl silychristin afforded a complex, inseparable mixture of the products.
    CONCLUSIONS:
    All isolated flavonolignan dimers exhibited significantly improved 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging activity compared to their monomers and, therefore, seem to be promising for further biological studies.
    Carasinol D

    Catalog No: CFN95044
    CAS No: 1072797-66-0
    Price: $333/5mg
    Lappaol C

    Catalog No: CFN95068
    CAS No: 64855-00-1
    Price: $333/10mg
    (-)-Epiafzelechin 3-O-gallate

    Catalog No: CFN95081
    CAS No: 108907-43-3
    Price: $388/5mg
    Cassiaglycoside II

    Catalog No: CFN95130
    CAS No: 2241081-56-9
    Price: $368/5mg
    Spinacetin

    Catalog No: CFN95194
    CAS No: 3153-83-1
    Price: $318/5mg
    Lathyranoic acid A

    Catalog No: CFN95325
    CAS No: 850560-44-0
    Price: $318/5mg
    3-O-Methylellagic acid 3'-O-alpha-rhamnopyranoside

    Catalog No: CFN95375
    CAS No: 352280-34-3
    Price: $413/5mg
    6-Methoxyfraxinellone

    Catalog No: CFN95485
    CAS No: N/A
    Price: $318/10mg
    3',3'''-Binaringenin

    Catalog No: CFN95558
    CAS No: 145399-99-1
    Price: $413/5mg
    New compound 23

    Catalog No: CFN95587
    CAS No: N/A
    Price: $318/5mg